Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05611346 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers

Study acronym: HypnoDA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Enrollment closed, study ongoing Show 5 more changesShow less
    • Study completion moved earlier from Dec 2027 to Feb 2027
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 4 of 6 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  3. Primary endpoint revised
    • Secondary endpoints expanded, about 21 words
    • Eligibility criteria shortened, about 2 words
    v7
  4. Eligibility criteria shortened, about 1 wordv6
  5. Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Primary completion date: Nov 2026 to Feb 2027
    • Study completion date: May 2027 to Dec 2027
    • Start date changed from estimate of Sep 2024 to Aug 13, 2024
    • Site details revised
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Apr 2024 to Sep 2024v4
  2. Primary completion date: Nov 2024 to Nov 2026
    • Start date: Feb 2023 to Apr 2024
    • Study completion date: May 2025 to May 2027
    v3
  3. Start date: Nov 2022 to Feb 2023
    • Eligibility criteria shortened, about 3 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
Trial Details
NCT Number NCT05611346
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions
(from sponsor)		 Dermatitis
Related terms Dermatitis
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov